Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xinzhao Zuo
Institution:
The Affiliated Yongchuan Hospital of Chongqing Medical University
Observed institutions:
The Affiliated Yongchuan Hospital of Chongqing Medical University,
Chongqing Municipal Health Commission,
Chongqing Medical University
ORCID:
0000-0003-2001-9932
Observed ORCID:
0000-0003-2001-9932
OpenAlex ID:
A5004046445
Upregulation of LRRC8A by m 5 C modification-mediated mRNA stability suppresses apoptosis and facilitates tumorigenesis in cervical cancer
2023
·
Yanjie Chen
, Xinzhao Zuo
, et al.
·
International Journal of Biological Sciences
·
92
PDF
RNA m5C modification upregulates E2F1 expression in a manner dependent on YBX1 phase separation and promotes tumor progression in ovarian cancer
2024
·
Xiaoyi Liu
, Qinglv Wei
, et al.
·
Experimental & Molecular Medicine
·
72
PDF
The RNA-stability-independent role of the RNA m6A reader YTHDF2 in promoting protein translation to confer tumor chemotherapy resistance
2025
·
Tao Liu
, Dan Yang
, et al.
·
Molecular Cell
·
32
CSTF3 contributes to platinum resistance in ovarian cancer through alternative polyadenylation of lncRNA NEAT1 and generating the short isoform NEAT1_1
2024
·
Xin Luo
, Qinglv Wei
, et al.
·
Cell Death and Disease
·
24
hnRNPL phase separation activates PIK3CB transcription and promotes glycolysis in ovarian cancer
2025
·
Fengjiang Qin
, Yuya Wang
, et al.
·
Nature Communications
·
16
PDF
RETRACTED ARTICLE: Loss of Ras GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) inhibits the progression of ovarian cancer in coordination with ubiquitin-specific protease 10 (USP10)
2021
·
Mengyuan Li
, Yan Tang
, et al.
·
Bioengineered
·
15
SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification
2025
·
Xinzhao Zuo
, Jie Xu
, et al.
·
Cancer Research
·
11
IGF2BP2 binding to CPSF6 facilitates m6A‐mediated alternative polyadenylation of PUM2 and promotes malignant progression in ovarian cancer
2025
·
Xin Luo
, Qinglv Wei
, et al.
·
Clinical and Translational Medicine
·
7
ALYREF condensation stabilizes m5C-modified PARP10 mRNA and promotes PI3K-AKT signaling in ovarian cancer
2025
·
Hongyan Zhao
, Qinglv Wei
, et al.
·
The EMBO Journal
·
1
RNA modifications and metabolism in cancer: Mechanisms, cross-talk and therapeutic implications
2026
·
Xin Luo
, Xinzhao Zuo
, et al.
·
Seminars in Cancer Biology
Figure S1 from SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification
2025
·
Xinzhao Zuo
, Jie Xu
, et al.
Table S2 from SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification
2025
·
Xinzhao Zuo
, Jie Xu
, et al.
Data from SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification
2025
·
Xinzhao Zuo
, Jie Xu
, et al.
Figure S9 from SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification
2025
·
Xinzhao Zuo
, Jie Xu
, et al.
Figure S10 from SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification
2025
·
Xinzhao Zuo
, Jie Xu
, et al.
Figure S3 from SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification
2025
·
Xinzhao Zuo
, Jie Xu
, et al.
Figure S8 from SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification
2025
·
Xinzhao Zuo
, Jie Xu
, et al.
Figure S5 from SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification
2025
·
Xinzhao Zuo
, Jie Xu
, et al.
Figure S7 from SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification
2025
·
Xinzhao Zuo
, Jie Xu
, et al.
Figure S2 from SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification
2025
·
Xinzhao Zuo
, Jie Xu
, et al.
Table S1 from SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification
2025
·
Xinzhao Zuo
, Jie Xu
, et al.
Figure S6 from SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification
2025
·
Xinzhao Zuo
, Jie Xu
, et al.
Figure S4 from SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification
2025
·
Xinzhao Zuo
, Jie Xu
, et al.
Show more works
View as search
Works count:
23
Citation count:
270
H-index:
7
I10-index:
7
Year
Topic
Type